310 related articles for article (PubMed ID: 10777424)
1. The effect of 5-fluorouracil on Dupuytren fibroblast proliferation and differentiation.
Jemec B; Linge C; Grobbelaar AO; Smith PJ; Sanders R; McGrouther DA
Chir Main; 2000 Feb; 19(1):15-22. PubMed ID: 10777424
[TBL] [Abstract][Full Text] [Related]
2. Tamoxifen decreases fibroblast function and downregulates TGF(beta2) in dupuytren's affected palmar fascia.
Kuhn MA; Wang X; Payne WG; Ko F; Robson MC
J Surg Res; 2002 Apr; 103(2):146-52. PubMed ID: 11922728
[TBL] [Abstract][Full Text] [Related]
3. Generation of contractile force by cultured Dupuytren's disease and normal palmar fibroblasts.
Rayan GM; Tomasek JJ
Tissue Cell; 1994 Oct; 26(5):747-56. PubMed ID: 9437248
[TBL] [Abstract][Full Text] [Related]
4. Is Dupuytren's disease caused by an imbalance between proliferation and cell death?
Jemec B; Grobbelaar AO; Wilson GD; Smith PJ; Sanders R; McGrouther DA
J Hand Surg Br; 1999 Oct; 24(5):511-4. PubMed ID: 10597921
[TBL] [Abstract][Full Text] [Related]
5. 5-fluorouracil selectively inhibits collagen synthesis.
Bulstrode NW; Mudera V; McGrouther DA; Grobbelaar AO; Cambrey AD
Plast Reconstr Surg; 2005 Jul; 116(1):209-21; discussion 222-3. PubMed ID: 15988270
[TBL] [Abstract][Full Text] [Related]
6. Anti-fibrotic action of pirfenidone in Dupuytren's disease-derived fibroblasts.
Zhou C; Liu F; Gallo PH; Baratz ME; Kathju S; Satish L
BMC Musculoskelet Disord; 2016 Nov; 17(1):469. PubMed ID: 27835939
[TBL] [Abstract][Full Text] [Related]
7. Correlation of alpha-smooth muscle actin expression and contraction in Dupuytren's disease fibroblasts.
Tomasek J; Rayan GM
J Hand Surg Am; 1995 May; 20(3):450-5. PubMed ID: 7642925
[TBL] [Abstract][Full Text] [Related]
8. A prospective randomised clinical trial of the intra-operative use of 5-fluorouracil on the outcome of dupuytren's disease.
Bulstrode NW; Bisson M; Jemec B; Pratt AL; McGrouther DA; Grobbelaar AO
J Hand Surg Br; 2004 Feb; 29(1):18-21. PubMed ID: 14734063
[TBL] [Abstract][Full Text] [Related]
9. Post-transcriptional regulation of alpha-smooth muscle actin determines the contractile phenotype of Dupuytren's nodular cells.
Verjee LS; Midwood K; Davidson D; Eastwood M; Nanchahal J
J Cell Physiol; 2010 Sep; 224(3):681-90. PubMed ID: 20432463
[TBL] [Abstract][Full Text] [Related]
10. Screening of potential prodrugs on cells derived from Dupuytren's disease patients.
Kraljevic Pavelic S; Bratulic S; Hock K; Jurisic D; Hranjec M; Karminski-Zamola G; Zinic B; Bujak M; Pavelic K
Biomed Pharmacother; 2009 Sep; 63(8):577-85. PubMed ID: 19010640
[TBL] [Abstract][Full Text] [Related]
11. Androgen receptors in Dupuytren's contracture.
Pagnotta A; Specchia N; Greco F
J Orthop Res; 2002 Jan; 20(1):163-8. PubMed ID: 11853085
[TBL] [Abstract][Full Text] [Related]
12. Investigating the effects of Pirfenidone on TGF-β1 stimulated non-SMAD signaling pathways in Dupuytren's disease -derived fibroblasts.
Zhou C; Zeldin Y; Baratz ME; Kathju S; Satish L
BMC Musculoskelet Disord; 2019 Mar; 20(1):135. PubMed ID: 30927912
[TBL] [Abstract][Full Text] [Related]
13. The collagen changes of Dupuytren's contracture.
Murrell GA; Francis MJ; Bromley L
J Hand Surg Br; 1991 Aug; 16(3):263-6. PubMed ID: 1960490
[TBL] [Abstract][Full Text] [Related]
14. Periostin differentially induces proliferation, contraction and apoptosis of primary Dupuytren's disease and adjacent palmar fascia cells.
Vi L; Feng L; Zhu RD; Wu Y; Satish L; Gan BS; O'Gorman DB
Exp Cell Res; 2009 Dec; 315(20):3574-86. PubMed ID: 19619531
[TBL] [Abstract][Full Text] [Related]
15. The contractile properties and responses to tensional loading of Dupuytren's disease--derived fibroblasts are altered: a cause of the contracture?
Bisson MA; Mudera V; McGrouther DA; Grobbelaar AO
Plast Reconstr Surg; 2004 Feb; 113(2):611-21; discussion 622-4. PubMed ID: 14758224
[TBL] [Abstract][Full Text] [Related]
16. An insight into Dupuytren's contracture.
Murrell GA
Ann R Coll Surg Engl; 1992 May; 74(3):156-60; discussion 161. PubMed ID: 1616255
[TBL] [Abstract][Full Text] [Related]
17. Pharmacologic regulation of Dupuytren's fibroblast contraction in vitro.
Rayan GM; Parizi M; Tomasek JJ
J Hand Surg Am; 1996 Nov; 21(6):1065-70. PubMed ID: 8969433
[TBL] [Abstract][Full Text] [Related]
18. Cellular structure and biology of Dupuytren's disease.
Tomasek JJ; Vaughan MB; Haaksma CJ
Hand Clin; 1999 Feb; 15(1):21-34. PubMed ID: 10050239
[TBL] [Abstract][Full Text] [Related]
19. The role of the fibroblast in Dupuytren's contracture.
Murrell GA
Hand Clin; 1991 Nov; 7(4):669-80; discussion 681. PubMed ID: 1769989
[TBL] [Abstract][Full Text] [Related]
20. Cytokine manipulation of explanted Dupuytren's affected human palmar fascia.
Kuhn MA; Payne WG; Kierney PC; Pu LL; Smith PD; Siegler K; Ko F; Wang X; Robson MC
Int J Surg Investig; 2001; 2(6):443-56. PubMed ID: 12678125
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
